Cold Call

Pursuing Precision Medicine at Intermountain Healthcare

02.26.2019 - By HBR Presents / Brian KennyPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

What happens when Intermountain Healthcare invests resources in an innovative precision medicine unit to provide life-extending, genetically targeted therapies to late-stage cancer patients? Harvard Business School professors Richard Hamermesh and Kathy Giusti discuss the case and its connections to their work with the Kraft Precision Medicine Accelerator.

More episodes from Cold Call